S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Tekla Healthcare Investors Stock Forecast, Price & News

+0.18 (+0.75%)
(As of 11/26/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
109,948 shs
Average Volume
132,051 shs
Market Capitalization
$1.08 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive HQH News and Ratings via Email

Sign-up to receive the latest news and ratings for Tekla Healthcare Investors and its competitors with MarketBeat's FREE daily newsletter.

Tekla Healthcare Investors logo

About Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.


See More Headlines

Industry, Sector and Symbol

Investment offices, not elsewhere classified
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Market Cap
$1.08 billion
Not Optionable

Company Calendar

Dividend Payable
Fiscal Year End


Overall MarketRank

1.21 out of 5 stars

Finance Sector

1151st out of 1,340 stocks

Investment Offices, Not Elsewhere Classified Industry

89th out of 156 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions

How has Tekla Healthcare Investors' stock been impacted by Coronavirus (COVID-19)?

Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HQH stock has increased by 34.8% and is now trading at $24.08.
View which stocks have been most impacted by COVID-19

Are investors shorting Tekla Healthcare Investors?

Tekla Healthcare Investors saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 165,100 shares, a decline of 37.4% from the October 31st total of 263,600 shares. Based on an average daily volume of 108,900 shares, the days-to-cover ratio is presently 1.5 days.
View Tekla Healthcare Investors' Short Interest

How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?

Tekla Healthcare Investors announced a quarterly dividend on Monday, November 15th. Stockholders of record on Wednesday, November 24th will be given a dividend of $0.51 per share on Friday, December 31st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 8.47%. The ex-dividend date of this dividend is Tuesday, November 23rd.
View Tekla Healthcare Investors' dividend history

Is Tekla Healthcare Investors a good dividend stock?

Tekla Healthcare Investors pays an annual dividend of $2.52 per share and currently has a dividend yield of 10.54%. HQH has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Tekla Healthcare Investors' dividend history.

Who are Tekla Healthcare Investors' key executives?

Tekla Healthcare Investors' management team includes the following people:
  • Dan Omstead, President & Trustee
  • Laura F. Woodward, Secretary, Treasurer & Chief Compliance Officer

What other stocks do shareholders of Tekla Healthcare Investors own?

What is Tekla Healthcare Investors' stock symbol?

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

Who are Tekla Healthcare Investors' major shareholders?

Tekla Healthcare Investors' stock is owned by a number of retail and institutional investors. Top institutional investors include Morgan Stanley (7.21%), Royal Bank of Canada (1.19%), Raymond James Financial Services Advisors Inc. (0.72%), LPL Financial LLC (0.71%), UBS Group AG (0.69%) and Raymond James & Associates (0.59%).
View institutional ownership trends for Tekla Healthcare Investors

Which institutional investors are selling Tekla Healthcare Investors stock?

HQH stock was sold by a variety of institutional investors in the last quarter, including Cetera Investment Advisers, Royal Bank of Canada, Raymond James & Associates, Oppenheimer & Co. Inc., Laidlaw Wealth Management LLC, Stephens Inc. AR, B. Riley Wealth Management Inc., and HighTower Advisors LLC.
View insider buying and selling activity for Tekla Healthcare Investors
or view top insider-selling stocks.

Which institutional investors are buying Tekla Healthcare Investors stock?

HQH stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, U.S. Capital Wealth Advisors LLC, Private Advisor Group LLC, LPL Financial LLC, Cetera Advisor Networks LLC, UBS Group AG, Rockefeller Capital Management L.P., and StoneX Group Inc..
View insider buying and selling activity for Tekla Healthcare Investors
or or view top insider-buying stocks.

How do I buy shares of Tekla Healthcare Investors?

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Healthcare Investors' stock price today?

One share of HQH stock can currently be purchased for approximately $24.08.

How much money does Tekla Healthcare Investors make?

Tekla Healthcare Investors has a market capitalization of $1.08 billion.

How many employees does Tekla Healthcare Investors have?

Tekla Healthcare Investors employs 147,000 workers across the globe.

What is Tekla Healthcare Investors' official website?

The official website for Tekla Healthcare Investors is www.teklacap.com.

Where are Tekla Healthcare Investors' headquarters?

Tekla Healthcare Investors is headquartered at 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109.

How can I contact Tekla Healthcare Investors?

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at (617) 772-8500, via email at [email protected], or via fax at 617-772-8577.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.